XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Aster Launches DNA Perpetuals With Up to 5x Leverage
Aster launched $DNA perpetuals on October 16, 2026, with a stated maximum leverage of up to 5x, expanding its derivatives lineup through the exchange’s on-chain...
BIS Says Stablecoins Compete Directly With Bank Deposits
The Bank for International Settlements has concluded that stablecoins compete directly with traditional bank deposits, positioning dollar-pegged digital tokens...
Binance Pool Ends Mining Work Credits Nov. 10: What Miners Need to Do
Binance Pool will stop crediting mining work on November 10, giving active miners a firm deadline to reconfigure their equipment and migrate to an alternative p...
Fortitude Discloses $8.3M Borrowed Zcash Sale in Update
Fortitude Mining Holdings disclosed in an Oct. 5 expansion update that it drew approximately $8.
Deutsche Bank to Launch Crypto Custody Services
Custody is not trading, investing, or payments. A custodian holds and safeguards assets, including the private keys that prove ownership of digital tokens, on b...
Eclair v0.14.4 Blocks Forged Browser Commands to ACINQ API
The core issue addressed by the release is cross-origin request forgery at the API layer: a crafted webpage could send commands to a locally accessible Eclair A...
